Hsa-miR-483-5p/mRNA network that regulates chemotherapy resistance in locally advanced rectal cancer identified through plasma exosome transcriptomics

Table 1 The College of American Pathologists standards and the group information

The criteria of CAP standards for the assessment of tumor response to nCRT
Good responder	CAP0	Complete response with no viable tumor cells
	CAP1	Only small clusters or single cancer cells remained
Poor-responder	CAP2	Residual tumor cells remaining, but with predominant fibrosis
	CAP3	Poor response with extensive residual tumor cells
The sub-group information of this study
Groups	Group 1	Poor responders before nCRT
	Group 2	Good responders before nCRT
	Group 3	Poor responders after nCRT
	Group 4	Good responders after nCRT

nCRT: Neoadjuvant chemoradiotherapy; CAP: College of American Pathologists.